Home Top Movers How Come Ovid Therapeutics Is On The Rise Today?

How Come Ovid Therapeutics Is On The Rise Today?

Price of the biopharmaceutical company Ovid Therapeutics Inc. (NASDAQ: OVID) is on an uptick in early trades today. The stock was at a rise of +47.13% to $4.36 as of 11:09 a.m. EST followed by news of a global rights deal struck by the company.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

What does the deal say?


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Ovid Therapeutics Inc. is a New York-based biopharmaceutical company that is transforming the lives of patients with rare neurological disorders developing treatments through its BoldMedicine approach.

Read More

There are many potential first-in-class medicines in the pipeline at Ovid.

Angelman syndrome, Fragile X syndrome, and rare epilepsies are among these programs, as are programs targeting other monogenetic disorders, which are in their early stages.

Announced today is a new exclusive agreement has been concluded between Takeda Pharmaceutical Company Limited (NYSE:TAK) and Ovid.

  • Under the terms of the agreement, Takeda will secure global rights on closing from Ovid for the development and commercialization of the investigational drug soticlestat targeted against Dravet syndrome (DS) and Lennox Gastaut syndrome (LGS).
  • Soticlestat is the first-in-class inhibitor of cholesterol 24-hydroxylase (CH24H) discovered at Takeda Research Center in Shonan, Japan.
  • Takeda has secured all global rights to soticlestat from Ovid under the new exclusive agreement.
  • It will be Takeda’s sole responsibility to move forward with further development and commercialization throughout the world.
  • Ovid will no longer be held responsible for any future milestone payments or development and commercialization costs due to Takeda under the original collaboration agreement.
  • In addition to the $196 million upfront payment at closing, Ovid may receive an additional $660 million upon reaching milestones in the development, regulatory, and sales phases of the transaction.

    Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

  • In addition, tiered royalties of 11% to 20% will be paid to Ovid if the FDA approves soticlestat and if it is commercialized.
  • Close of the agreement is expected to take place by the end of this month, subject to the satisfaction of regulatory requirements, including the Hart-Scott-Rodino Act.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Onesmart International Education Group Ltd. (ONE) stock surges during current market. What’s driving it high?

Onesmart International Education Group Ltd. (NASDAQ: ONE) stock gains by 111.86% in the current market trading session. OneSmart International Education is a major Chinese...

LivePerson Inc. (LPSN) stock plunge during pre-market. What’s driving it low?

LivePerson Inc. (NASDAQ: LPSN) stock gained by 0.86% at last close whereas the LPSN stock declines by 9.39% in the pre-market trading session. Through...

The Clorox Company Ltd. (CLX) stock decline during pre-market. Here’s the recent update

The Clorox Company Ltd. (NASDAQ: CLX) stock gained by 0.17% at last close whereas the CLX stock price fell by 11.59% in the pre-market....

IT Tech Packaging Inc. (ITP) stock gains during pre-market. Here’s what’s happening?

IT Tech Packaging Inc. (NASDAQ: ITP) stock gained by 7.53% at last close while the ITP stock price rises by 2.04% in the pre-market...

Why did The9 Limited (NCTY) stock turnaround in the after-hours on Friday?

The9 Limited (NCTY) shares gained 6.87% in after-hours on Friday, July 30, 2021, and closed the weekly trading at $11.98 per share. in the...

Here is why MicroVision Inc. (MVIS) stock surged in the after-hours on Wednesday?

MicroVision Inc. (MVIS) shares surged 14.98% in after-hours on Wednesday, August 04, 2021, and closed the daily trading at $14.05 per share. In the...

Onesmart International Education Group Ltd. (ONE) stock surges during current market. What’s driving it high?

Onesmart International Education Group Ltd. (NASDAQ: ONE) stock gains by 111.86% in the current market trading session. OneSmart International Education is a major Chinese...

OneConnect Financial Technology Inc. (OCFT) stock plunge during current market. Here’s what you should know.

OneConnect Financial Technology Inc. (NASDAQ: OCFT) stock declines by 22.12% in the current market trading. In China, OneConnect is the most popular technology-as-a-service platform...

Related News

Why did Etsy Inc. (ETSY) shares decline in the after-markets on Wednesday?

Etsy Inc. (ETSY) shares declined 13.81% in after-hours on Wednesday, August 04, 2021, and closed the daily trading at $174.20 per share. In the...

Here is why MicroVision Inc. (MVIS) stock surged in the after-hours on Wednesday?

MicroVision Inc. (MVIS) shares surged 14.98% in after-hours on Wednesday, August 04, 2021, and closed the daily trading at $14.05 per share. In the...

Here is why Activision Blizzard Inc. (ATVI) stock turnaround in the after-hours on Tuesday?

Activision Blizzard Inc. (ATVI) shares gained 6.10% in after-hours on Tuesday, August 03, 2021, and closed the daily trading at $84.70 per share. Earlier...

Lixte Biotechnology Holdings Inc. (LIXT) stock surge during current market. Here’s the recent news

Lixte Biotechnology Holdings Inc. (NASDAQ: LIXT) stock gains by 32.32% in the current market trading session. Lixte Biotechnology Holdings is a clinical-stage pharmaceutical business...

Arcturus Therapeutics Inc. (ARCT) stock surged during pre-market. Here’s the latest news.

Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) stock gained by 10.7% at last close while the ARCT stock rises by 7.53% in the pre-market trading...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam